BIOVENTRIX, INC.

Profile

Company Names

BIOVENTRIX, INC.
BIOVENTRIX INC
CHF TECHNOLOGIES INC

Addresses

120 FORBES BLVD., SUITE 125, MANSFIELD, MA 02048

12647 ALCOSTA BOULEVARD, SUITE 400, SAN RAMON, CA 94583

12647 ALCOSTA BLVD., SUITE 400, SAN RAMON, CA 94583

Phone Numbers

(925) 830-1000
925-830-1000

 

Entity Type:

CORPORATION

Industry:

OTHER, BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

CALIFORNIA

Total Amount Raised:

$214,981,243.00

Number of Funding Rounds:

25
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
25
2026-04-16 
$705,000.00 
$6,000,000.00 
$5,295,000.00 
 
24
2024-10-10 
$6,672,600.00 
$12,000,000.00 
$5,327,400.00 
 
23
2024-03-22 
$3,000,000.00 
$3,000,000.00 
$0.00 
Equity 
22
2023-03-30 
$12,650,000.00 
$15,650,000.00 
$3,000,000.00 
Equity 
21
2023-01-13 
$1,977,000.00 
$3,000,000.00 
$1,023,000.00 
 
20
2022-04-01 
$1,000,000.00 
$10,000,000.00 
$9,000,000.00 
Equity 
19
2022-01-06 
$5,978,677.00 
$5,978,677.00 
$0.00 
Equity 
18
2020-12-21 
$40,755,720.00 
$45,000,000.00 
$4,244,280.00 
Equity 
17
2020-01-02 
$14,755,700.00 
$25,000,000.00 
$10,244,300.00 
 
16
2019-07-19 
$2,549,200.00 
$3,900,000.00 
$1,350,800.00 
Equity 
15
2017-08-25 
$40,000,000.00 
$40,000,000.00 
$0.00 
Equity 
14
2016-07-21 
$14,504,967.00 
$14,504,967.00 
$0.00 
Equity 
13
2014-12-12 
$14,000,000.00 
$17,500,000.00 
$3,500,000.00 
Equity 
12
2014-01-24 
$12,430,879.00 
$12,430,879.00 
$0.00 
Equity 
11
2013-12-03 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity 
10
2013-04-12 
$6,539,187.00 
$8,000,000.00 
$1,460,813.00 
Equity 
9
2012-11-08 
$4,500,000.00 
$4,500,000.00 
$0.00 
Equity 
8
2012-04-09 
$5,073,540.00 
$7,000,000.00 
$1,926,460.00 
Equity 
7
2012-02-22 
$330,000.00 
$6,000,000.00 
$5,670,000.00 
Equity 
6
2012-02-15 
$0.00 
INDEFINITE 
INDEFINITE 
 
5
2011-10-31 
$5,985,817.00 
$10,000,000.00 
$4,014,183.00 
Equity, Debt 
4
2011-09-23 
$5,052,817.00 
$10,000,000.00 
$4,947,183.00 
Equity, Debt 
3
2011-08-18 
$5,052,817.00 
$10,000,000.00 
$4,947,183.00 
Equity, Debt 
2
2010-12-30 
$3,867,817.00 
$10,000,000.00 
$6,132,183.00 
Equity, Debt 
1
2009-10-03 
$5,599,505.00 
$5,599,505.00 
$0.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
WILLIAM 
 
ABBOTT 
EXECUTIVE OFFICER
WILLIAM 
 
ABRAHAM 
DIRECTOR
WILLIAM 
T. 
ABRAHAM 
DIRECTOR
LON 
 
AMNEST 
EXECUTIVE OFFICER
LON 
 
ANNEST 
EXECUTIVE OFFICER
LAUREN 
 
BAKER 
DIRECTOR
ORI 
 
BEN-YEHUDA 
EXECUTIVE OFFICER
ARTHUR 
 
BERTOLERO 
DIRECTOR
STEVE 
 
CHARTIER 
EXECUTIVE OFFICER
STEVEN 
 
CHARTIER 
EXECUTIVE OFFICER, DIRECTOR
ANDREW 
 
COATS 
DIRECTOR
RAYMOND 
 
COHEN 
DIRECTOR
JAMES 
 
DILLON 
EXECUTIVE OFFICER, DIRECTOR
GEORGE 
 
FAZIO 
DIRECTOR
GERALD 
 
GRAYSON 
DIRECTOR
STEPHEN 
 
HEALY 
DIRECTOR
STEVEN 
 
HEALY 
DIRECTOR, EXECUTIVE OFFICER
ANDREW 
 
HINSON 
DIRECTOR
MILLER 
 
KEN 
EXECUTIVE OFFICER, DIRECTOR
NOEL 
 
MESSENGER 
EXECUTIVE OFFICER
KEN 
 
MILLER 
EXECUTIVE OFFICER, DIRECTOR
KENNETH 
 
MILLER 
EXECUTIVE OFFICER, DIRECTOR
KENNETH 
MILLER 
EXECUTIVE OFFICER, DIRECTOR
THASEEGARAN 
 
PILLAY, M.D. 
EXECUTIVE OFFICER
WARREN 
 
PINCKERT 
DIRECTOR
WARREN 
E. 
PINCKERT, II 
DIRECTOR
WARREN 
 
PINKERT II 
DIRECTOR
WARREN 
E. 
PINKERT II 
DIRECTOR
WARREN 
E. 
PINKERT, II 
DIRECTOR
RISHI 
 
PURI 
DIRECTOR
MARK 
 
RAVICH 
DIRECTOR
DAVID 
 
RICHMOND 
DIRECTOR, EXECUTIVE OFFICER
RINDA 
 
SAMA 
DIRECTOR
PAUL 
 
SEID 
DIRECTOR
KEVIN 
 
VAN BLADEL 
EXECUTIVE OFFICER
KEVIN 
 
VON BLADEL 
EXECUTIVE OFFICER
CHRISTOPHER 
 
WOLFF 
EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
OTHER 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
 
2026-04-16 
D/A
OTHER 
SURGICAL + MEDICAL INSTRUMENTS + APPARATUS [3841] 
DECLINE TO DISCLOSE 
 
2024-10-10 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
 
2024-10-10 
D
OTHER 
 
DECLINE TO DISCLOSE 
 
2024-10-10 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-03-22 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2024-03-22 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-30 
D
OTHER 
 
DECLINE TO DISCLOSE 
 
2023-01-13 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2022-04-01 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-06 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-21 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
 
2020-01-02 
D
OTHER 
 
DECLINE TO DISCLOSE 
 
2020-01-02 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-07-19 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-25 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-25 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-25 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-25 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-25 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-25 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2016-07-21 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
 
2016-07-21 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
 
2016-07-21 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
 
2016-07-21 
D
OTHER 
 
DECLINE TO DISCLOSE 
 
2016-07-21 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-12 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-12 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-12 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-24 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-01-24 
D
OTHER 
 
NOT APPLICABLE 
Equity 
2014-01-24 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-03 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2013-12-03 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-12 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-12 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-08 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-08 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2012-11-08 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-09 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2012-04-09 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-22 
D
OTHER 
 
DECLINE TO DISCLOSE 
 
2012-02-15 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-10-31 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-09-23 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2011-08-18 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-12-30 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-12-30 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-12-30 
D
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-12-30 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2009-10-03 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2009-10-03 
D/A
OTHER 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2009-10-03 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2009-10-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
THE BENCHMARK COMPANY, LLC
RAY REYNA JR.
THIRD500, LLC
FREDERICK REICHENBACH
FINALIS SECURITIES LLC
THOMAS C. ARMSTRONG
NONE
NONE
TAGLICH BROTHERS, INC.
NONE
NONE
TAGLICH BROTHERS, INC.
NONE
NONE
NONE
TAGLICH BROTHERS, INC.
NONE
NONE
TAGLICH BROTHERS, INC.